Literature DB >> 16469947

Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness.

Hiroshi Watanabe1, Sanni Söderlund, Aino Soro-Paavonen, Anne Hiukka, Eeva Leinonen, Corradina Alagona, Riitta Salonen, Tomi-Pekka Tuomainen, Christian Ehnholm, Matti Jauhiainen, Marja-Riitta Taskinen.   

Abstract

OBJECTIVE: High-density lipoprotein (HDL) cholesterol correlates inversely with the risk of coronary heart disease (CHD). The precise antiatherogenic mechanisms of HDL subspecies are not thoroughly elucidated. We studied the relationship between carotid intima-media thickness (IMT) and HDL subspecies distribution in Finnish families with low HDL cholesterol and premature CHD. METHODS AND
RESULTS: Altogether, 148 members of Finnish low-HDL families and 133 healthy control subjects participated in our study. HDL particle size was significantly smaller in affected family members (HDL < or =10th Finnish age-sex specific percentile) compared with unaffected family members and control subjects (9.1+/-0.04 nm versus 9.5+/-0.05 nm, P<0.0001, versus 9.8+/-0.03 nm, P<0.0001 [mean+/-SE]). Large HDL2b particles as well as prebeta-HDL concentration were significantly decreased among the affected family members. Mean IMT was significantly higher in the affected family members than in the control subjects (0.85+/-0.01 mm versus 0.79+/-0.01 mm; P<0.0001). Age, HDL2b, systolic blood pressure, and prebeta-HDL were significant independent determinants of mean IMT.
CONCLUSIONS: The decreased levels of HDL2b and prebeta-HDL reflect the potentially efflux-deficient HDL subspecies profile in the affected low-HDL family members. Decreased HDL particle size caused by the decrease of plasma concentration of HDL2b and decreased prebeta-HDL levels correlate with increased IMT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469947     DOI: 10.1161/01.ATV.0000209577.04246.c0

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

Review 1.  Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development.

Authors:  Geesje M Dallinga-Thie; Robin P F Dullaart; Arie van Tol
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

2.  Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.

Authors:  Laxman Yetukuri; Sanni Söderlund; Artturi Koivuniemi; Tuulikki Seppänen-Laakso; Perttu S Niemelä; Marja Hyvönen; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Oresic
Journal:  J Lipid Res       Date:  2010-04-29       Impact factor: 5.922

Review 3.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

4.  Effect of ezetimibe on low- and high-density lipoprotein subclasses in sitosterolemia.

Authors:  Rgia A Othman; Semone B Myrie; David Mymin; Jean-Baptiste Roullet; Robert D Steiner; Peter J H Jones
Journal:  Atherosclerosis       Date:  2017-03-10       Impact factor: 5.162

5.  Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function.

Authors:  Stephanie T Page; Ronald M Krauss; Coleman Gross; Brian Ishida; Jay W Heinecke; Chongren Tang; John K Amory; Peter M Schaefer; Cheryl J Cox; John Kane; Jonathan Q Purnell; Richard L Weinstein; Tomáš Vaisar
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

6.  Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.

Authors:  Zhenghui G Jiang; Elliot B Tapper; Misung Kim; Margery A Connelly; Sarah A Krawczyk; Eric U Yee; Mark A Herman; Kenneth J Mukamal; Michelle Lai
Journal:  J Clin Gastroenterol       Date:  2018 May/Jun       Impact factor: 3.062

7.  A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.

Authors:  Michele L Mietus-Snyder; Mark K Shigenaga; Jung H Suh; Swapna V Shenvi; Ashutosh Lal; Tara McHugh; Don Olson; Joshua Lilienstein; Ronald M Krauss; Ginny Gildengoren; Joyce C McCann; Bruce N Ames
Journal:  FASEB J       Date:  2012-05-01       Impact factor: 5.191

8.  The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution.

Authors:  Li Tian; Yanhua Xu; Mingde Fu; Tao Peng; Yinghui Liu; Shiyin Long
Journal:  Lipids Health Dis       Date:  2011-01-21       Impact factor: 3.876

9.  The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Authors:  Margarita de la Llera-Moya; Denise Drazul-Schrader; Bela F Asztalos; Marina Cuchel; Daniel J Rader; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-14       Impact factor: 8.311

Review 10.  Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions.

Authors:  Ozlem Bilen; Ayeesha Kamal; Salim S Virani
Journal:  World J Cardiol       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.